Tag: Diabetes: Type II
Studies Often Fail to Include Info on T2DM Medication Adherence
Relative risks of good versus poor adherence to meds reduced for all-cause mortality, hospitalization
Lifestyle Intervention Only Offers Modest Benefit in Type 2 Diabetes
Change in glycemic control did not reach criterion for equivalence among adults diagnosed for <10 years
Sleep Duration Inversely Linked to Risk Markers of T2DM in Kids
Strong inverse correlations between sleep duration, adiposity, diabetes risk markers in children
Team-Based Online Game May Improve Glycemic Control in T2D
Participation in diabetes self-management education game linked to sustained HbA1c reduction
Mortality Down Only for Gastric Bypass Patients With Diabetes
RYGB patients without diabetes did not have significantly improved mortality compared to controls
Ipragliflozin Beneficial in T2DM Complicated by Liver Disease
Effect similar to pioglitazone, with reduction in body weight, abdominal fat only for ipragliflozin
Similar Defects ID’d for T2DM, Chronic Pancreatitis and Diabetes
Similarly disturbed α-cell responses to oral glucose ingestion and hypoglycemia
Canagliflozin Delays Increase in Certain CV Biomarkers in T2DM
Canagliflozin may reduce CV, heart failure risk over two years versus placebo in older patients with T2DM
Diabetes Symptoms Appear to Spread Via Prion-Like Mechanism
Injections in mice led to symptoms of the disease, researchers report
Moderate Drinking May Be Protective Against Diabetes
Wine appears to provide the most protective benefit, researchers say